181 related articles for article (PubMed ID: 23119090)
21. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population.
Socan M; Prosenc K; Vegnuti M
Wien Klin Wochenschr; 2006 Jun; 118(11-12):336-40. PubMed ID: 16855922
[TBL] [Abstract][Full Text] [Related]
22. Impaired long-term maintenance and function of Bordetella pertussis specific B cell memory.
Stenger RM; Smits M; Kuipers B; van Gaans-van den Brink J; Poelen M; Boog CJ; van Els CA
Vaccine; 2010 Sep; 28(40):6637-46. PubMed ID: 20637762
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
Front Immunol; 2019; 10():2423. PubMed ID: 31681310
[No Abstract] [Full Text] [Related]
24. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
Greenberg DP; Doemland M; Bettinger JA; Scheifele DW; Halperin SA; ; Waters V; Kandola K
Pediatr Infect Dis J; 2009 Jun; 28(6):521-8. PubMed ID: 19436236
[TBL] [Abstract][Full Text] [Related]
26. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins.
Hendrikx LH; Oztürk K; de Rond LG; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Feb; 29(7):1431-7. PubMed ID: 21187178
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of antibody to Bordetella pertussis in neonates and prevalence of recent pertussis infection in pregnant women in Catalonia (Spain) in 2003 and 2013.
Plans P; Álvarez E; de Ory F; Campins M; Payà T; Balfagón P; Godoy P; Caylà J; Carreras R; Cabero L; Domínguez A;
Pediatr Infect Dis J; 2014 Nov; 33(11):1114-8. PubMed ID: 24871642
[TBL] [Abstract][Full Text] [Related]
28. [Humoral imunity to pertussis in children with diabetes of type 1].
Tarasova AA; Kostinov MP; Zaĭtsev EM
Zh Mikrobiol Epidemiol Immunobiol; 2006; (3):53-7. PubMed ID: 16830591
[TBL] [Abstract][Full Text] [Related]
29. Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.
Podda A; Bona G; Canciani G; Pistilli AM; Contu B; Furlan R; Meloni T; Stramare D; Titone L; Rappuoli R
J Pediatr; 1995 Aug; 127(2):238-43. PubMed ID: 7636648
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
[TBL] [Abstract][Full Text] [Related]
31. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
32. Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.
Esposito S; Agliardi T; Giammanco A; Faldella G; Cascio A; Bosis S; Friscia O; Clerici M; Principi N
Infect Immun; 2001 Jul; 69(7):4516-20. PubMed ID: 11401994
[TBL] [Abstract][Full Text] [Related]
33. Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activity.
Aase A; Herstad TK; Merino S; Bolstad M; Sandbu S; Bakke H; Aaberge IS
Clin Vaccine Immunol; 2011 Aug; 18(8):1269-74. PubMed ID: 21677109
[TBL] [Abstract][Full Text] [Related]
34. Pertussis vaccination during pregnancy in Belgium: Follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age.
Maertens K; Caboré RN; Huygen K; Vermeiren S; Hens N; Van Damme P; Leuridan E
Vaccine; 2016 Jun; 34(31):3613-9. PubMed ID: 27142328
[TBL] [Abstract][Full Text] [Related]
35. Clustered cases of Bordetella pertussis infection cause high levels of IgG antibodies against pertussis toxin in adolescents in Gaobeidian city, China.
Wu Y; Zhu B; Gao Y; Shi Z; Wang J; Wang H; Shao Z
Epidemiol Infect; 2014 Apr; 142(4):738-43. PubMed ID: 24308586
[TBL] [Abstract][Full Text] [Related]
36. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of high antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants.
Esen B; Coplu N; Kurtoglu D; Gozalan A; Akin L
J Clin Lab Anal; 2007; 21(3):154-61. PubMed ID: 17506474
[TBL] [Abstract][Full Text] [Related]
38. No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe.
Levine OS; Lagos R; Losonsky GA; San Martin O; Abrego P; Bustamante C; Wasserman SS; Levine MM
J Infect Dis; 1996 Dec; 174(6):1341-4. PubMed ID: 8940230
[TBL] [Abstract][Full Text] [Related]
39. Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine.
Halperin SA; Langley JM; Eastwood BJ
Clin Infect Dis; 1996 Jan; 22(1):59-62. PubMed ID: 8824967
[TBL] [Abstract][Full Text] [Related]
40. Pertussis seroimmunity among mother-infant pairs and infant immune response to pertussis vaccination.
Saffar MJ; Ajami A; Khalilian AR; Qaheri A; Saffar H
Indian Pediatr; 2007 Dec; 44(12):916-8. PubMed ID: 18175845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
